While psychedelics research was more of a niche within science in the sixties and seventies (you may have heard of the Good Friday experiment?), more recently, it has grown a solid scientific basis. Research into the effects, mechanics of action and potential therapeutic use currently takes place at renowned institutes such as the Imperial College in London, Yale University, the Johns Hopkins School of Medicine in Baltimore and New York University.
This month, for example, groundbreaking research on the effects of LSD using brain scans was published.
Amsterdam is one of the few European cities that offers a platform for these researchers, by hosting the Interdisciplinary Conference on Psychedelics Research 2016 on 3 – 5 June.
ICPR 2016 - 3/4/5 June, Amsterdam
During this three-day event, more than fifty international and national researchers from a wide range of academic disciplines will present their findings on the uses and (therapeutic) effects of psychedelic substances such as LSD, psilocybin, ayahuasca, MDMA, ibogaïne and ketamine.
The larger part of research focuses on therapeutic uses in patients who suffer from depression, addiction, PTSD and anxiety disorders (such as end-of- life anxiety and social anxiety).
See the full list of speakers: www.icpr2016.nl/speakers
ICPR 2016 is the third scientific congress on psychedelics organised by the OPEN Foundation. The congress is sponsored by OSF, MAPS and the Beckley Foundation.
Get tickets: www.icpr2016.nl/tickets
